250 related articles for article (PubMed ID: 31997554)
1. The difficult management of persistent, non-focal congenital hyperinsulinism: A retrospective review from a single, tertiary center.
Rasmussen AG; Melikian M; Globa E; Detlefsen S; Rasmussen L; Petersen H; Brusgaard K; Rasmussen AH; Mortensen MB; Christesen HT
Pediatr Diabetes; 2020 May; 21(3):441-455. PubMed ID: 31997554
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, outcome, and predictors of neurological sequelae of persistent congenital hyperinsulinism: A single tertiary center experience.
Laimon W; Aboelenin HM; El Tantawi NT
Pediatr Diabetes; 2021 May; 22(3):388-399. PubMed ID: 33528087
[TBL] [Abstract][Full Text] [Related]
3. Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.
Salomon-Estebanez M; Flanagan SE; Ellard S; Rigby L; Bowden L; Mohamed Z; Nicholson J; Skae M; Hall C; Craigie R; Padidela R; Murphy N; Randell T; Cosgrove KE; Dunne MJ; Banerjee I
Orphanet J Rare Dis; 2016 Dec; 11(1):163. PubMed ID: 27908292
[TBL] [Abstract][Full Text] [Related]
4. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.
Xu A; Cheng J; Sheng H; Wen Z; Lin Y; Zhou Z; Zeng C; Shao Y; Li C; Liu L; Li X
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):400-409. PubMed ID: 31208162
[TBL] [Abstract][Full Text] [Related]
5. Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.
Welters A; Meissner T; Grulich-Henn J; Fröhlich-Reiterer E; Warncke K; Mohnike K; Blankenstein O; Menzel U; Datz N; Bollow E; Holl RW
Orphanet J Rare Dis; 2018 Dec; 13(1):230. PubMed ID: 30577875
[TBL] [Abstract][Full Text] [Related]
6. Congenital hyperinsulinism: management and outcome, a single tertiary centre experience.
El Tonbary K; Robinson P; Banerjee I; Shaikh MG
Eur J Pediatr; 2020 Jun; 179(6):947-952. PubMed ID: 32002613
[TBL] [Abstract][Full Text] [Related]
7. Molecular Characterization and Management of Congenital Hyperinsulinism: A Tertiary Centre Experience.
Sharma R; Roy K; Satapathy AK; Kumar A; Nanda PM; Damle N; Houghton JAL; Flanagan SE; Radha V; Mohan V; Jain V
Indian Pediatr; 2022 Feb; 59(2):105-109. PubMed ID: 34992182
[TBL] [Abstract][Full Text] [Related]
8. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.
Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ
Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418
[TBL] [Abstract][Full Text] [Related]
9. Hyperinsulinism in the Neonate.
Lord K; De León DD
Clin Perinatol; 2018 Mar; 45(1):61-74. PubMed ID: 29406007
[TBL] [Abstract][Full Text] [Related]
10. Genetic characteristics of patients with congenital hyperinsulinism.
Vajravelu ME; De León DD
Curr Opin Pediatr; 2018 Aug; 30(4):568-575. PubMed ID: 29750770
[TBL] [Abstract][Full Text] [Related]
11. An Egyptian case of congenital hyperinsulinism of infancy due to a novel mutation in KCNJ11 encoding Kir6.2 and response to octreotide.
Sherif EM; Abdelmaksoud AA; Elbarbary NS; Njølstad PR
Acta Diabetol; 2013 Oct; 50(5):801-5. PubMed ID: 20686794
[TBL] [Abstract][Full Text] [Related]
12. Congenital hyperinsulinism: current trends in diagnosis and therapy.
Arnoux JB; Verkarre V; Saint-Martin C; Montravers F; Brassier A; Valayannopoulos V; Brunelle F; Fournet JC; Robert JJ; Aigrain Y; Bellanné-Chantelot C; de Lonlay P
Orphanet J Rare Dis; 2011 Oct; 6():63. PubMed ID: 21967988
[TBL] [Abstract][Full Text] [Related]
13. Congenital hyperinsulinism and surgical outcome in a single tertiary center in Brazil.
Liberatore RDR; Monteiro ICM; Pileggi FO; Canesin WC; Sbragia L
J Pediatr (Rio J); 2024; 100(2):163-168. PubMed ID: 37866397
[TBL] [Abstract][Full Text] [Related]
14. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
Jindal R; Ahmad A; Siddiqui MA; Kochar IS; Wangnoo SK
Diabetes Metab Syndr; 2014; 8(1):45-7. PubMed ID: 24661758
[TBL] [Abstract][Full Text] [Related]
15. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.
Banerjee I; Skae M; Flanagan SE; Rigby L; Patel L; Didi M; Blair J; Ehtisham S; Ellard S; Cosgrove KE; Dunne MJ; Clayton PE
Eur J Endocrinol; 2011 May; 164(5):733-40. PubMed ID: 21378087
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of medically-refractory hyperinsulinism.
Zobel MJ; McFarland C; Ferrera-Cook CT; Padilla BE
Am J Surg; 2020 Jun; 219(6):947-951. PubMed ID: 31757439
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
[TBL] [Abstract][Full Text] [Related]
18. Congenital hyperinsulinism in Chinese patients: 5-yr treatment outcome of 95 clinical cases with genetic analysis of 55 cases.
Gong C; Huang S; Su C; Qi Z; Liu F; Wu D; Cao B; Gu Y; Li W; Liang X; Liu M
Pediatr Diabetes; 2016 May; 17(3):227-34. PubMed ID: 25639667
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and long-term outcome of Taiwanese children with congenital hyperinsulinism.
Lee CT; Liu SY; Tung YC; Chiu PC; Wu MZ; Tsai WY
J Formos Med Assoc; 2016 May; 115(5):306-10. PubMed ID: 25960244
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and phenotype-genotype review of 25 Omani children with congenital hyperinsulinism in infancy. A one-decade single-center experience.
Al-Badi MK; Al-Azkawi HS; Al-Yahyaei MS; Mula-Abed WA; Al-Senani AM
Saudi Med J; 2019 Jul; 40(7):669-674. PubMed ID: 31287126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
